Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12602745 | 0.84 | ALDH1A1 (0.32) | CYP1A2MEN1KMT2A | |
| SCHEMBL13888826 | 0.82 | ALDH1A1 (0.33) | ERBB2CYP1A2FYNMAOAACHE | |
| SCHEMBL15316869 | 0.82 | ALDH1A1 (0.33) | ERBB2CYP1A2FYNMAOAACHE | |
| SCHEMBL10028173 | 0.81 | ALDH1A1 (0.32) | CYP1A2MEN1KMT2A | |
| SCHEMBL16271393 | 0.80 | PDK2 (0.34) | ERBB2CYP1A2FYNMAOAACHE | |
| SCHEMBL12387545 | 0.79 | ALDH1A1 (0.38) | CYP1A2MEN1KMT2A | |
| SCHEMBL12602770 | 0.79 | ALDH1A1 (0.34) | CYP1A2MEN1KMT2A | |
| SCHEMBL12602765 | 0.79 | ERBB2 (0.33) | ERBB2CYP1A2FYNMAOAACHE | |
| SCHEMBL16271363 | 0.79 | — | — | |
| SCHEMBL16270000 | 0.79 | ALDH1A1 (0.32) | CYP1A2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8901298-B2 | Materials for organic electroluminescence devices | MERCK PATENT GMBH (DE) | 2014-12-02 | — | — | US | disclosed |
| US-8901298-B2 | Materials for organic electroluminescence devices | MERCK PATENT GMBH (DE) | 2014-12-02 | — | — | US | disclosed |
| US-20110112275-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
| US-20110112275-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
| WO-2010049050-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2010-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110112275-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | LAGE3, EML4, MCM4 | ERBB2 2510/4885CYP1A2 1092/4885FYN 2416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.